The Discounted Cash Flow (DCF) valuation of ANI Pharmaceuticals Inc (ANIP) is 51.18 USD. With the latest stock price at 58.16 USD, the upside of ANI Pharmaceuticals Inc based on DCF is -12.0%.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 9.2% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 27.74 - 121.83 | 51.18 |
| Upside | -52.3% - 109.5% | -12.0% |